<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677896/" ref="ordinalpos=2546&amp;ncbi_uid=4989291&amp;link_uid=PMC3677896" image-link="/pmc/articles/PMC3677896/figure/pone-0065032-g006/" class="imagepopup">Figure 6. Effects of SHH <span class="highlight" style="background-color:">signaling</span> agonists on tumor cell growth without dead cells..  From: Sonic Hedgehog <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Supports Cancer Cell Growth during Cancer Radiotherapy. </a></div><br /><div class="p4l_captionBody">A. SHH signaling agonist SAG enhances Panc1Fluc cell growth in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. **represents P&lt;0.01. B. SHH signaling agonist SAG enhances HT29Fluc cell growth in a dose-dependent manner. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. *represents P&lt;0.05, **represents P&lt;0.01. C. Panc1Fluc cells treated with N-terminal fragment Shh demonstrate increased growth. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. *represents P&lt;0.05. D. HT29Fluc cells treated with N-terminal fragment Shh demonstrate increased growth. Top: signal intensity analysis from bioluminescence image; Bottom: representative bioluminescence images; scale bar represents 1 cm. **represents P&lt;0.01.</div></div>